NAVIGATION
Pharmacovigilance Strategy Meeting Europe 2018

Proventa International will be gathering over 100 C-Level Directors from a mix of emerging to large Pharmaceutical, Biotechnology & Academic/Research Institutions to help solve their key strategic challenges in the area of Pharmacovigilance.

Register Now
24th May 2018, Sofitel, Munich
2018-05-24 07:30:00 2018-05-24 19:00:00 Europe/London Pharmacovigilance Strategy Meeting Europe 2018 24th May 2018, Sofitel, Munich Proventa International will be gathering over 100 C-Level Directors from a mix of emerging to large Pharmaceutical, Biotechnology & Academic/Research Institutions to help solve their key strategic challenges in the area of Pharmacovigilance. https://proventainternational.com/pharmacovigilance-europe-2018/ Sofitel Ambreen Anwer aa@proventainternational.com

AGENDA

The Pharmacovigilance Roundtable Discussions Strategy Meeting is free to attend for qualified end-users. These include Senior Executives of Pharmacovigilance (from medium to large Pharma, Biopharma and Biotech players) as well as thought leaders from Academia and regulatory authorities.

Thought leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:
– Pharmacovigilance, Risk Management, Drug Safety, Safety Surveillance, Clinical Safety, Patient Safety, Medical & Regulatory Affairs, Compliance, Post Authorisation Safety, Medical Safety, Epidemiology.

Those who do not qualify for complimentary passes, including vendors, exchanges, consultancies and other service providers, can apply here.

Pharmacovigilance Europe 2018

REQUEST AGENDA

Advisory Board

Media Partners

Testimonials

Pharma Supply Chain Europe 2016 ,  Return on Investment attained at the meeting and why they are coming back

Pharma Supply Chain Europe 2016 , Return on Investment attained at the meeting and why they are coming back

Pharma Supply Chain Europe 2016 , What they think of the roundtable discussion format

Pharma Supply Chain Europe 2016 , Level of delegation, attendee diversity and seniority

Pharma Supply Chain Europe 2016 , What they think of the 1-1 prequalified business meetings

Samuel T. Labrie, VP Corporate Development, Myriad RBM

Kam Dhaliwal, SVP Services & Alliances, Horizon Discovery

Matt Hersch, Clinical Operations Manager, GW Pharmaceuticals

Rainer Metzger, VP Global Business Development Pharma, Qiagen

Dilsaid Babayigit, Founder & CEO, Ageneo

John Apathy, Vice President, R&D informatics, Celgene

Lars Branden, Senor Director,Informatics R&D Division,Retro Screen Virology Ltd.

Dominic Clark , Industry Programme Manager,EMBL-EBI

Yike Guo, Director Data Science Institude, Imperial College London

John Wise, Executive Director, Pistoia Alliance

Abel Ureta-Vida, CEO, Eagle Genomics

Alexander Scheer, Deputy Head of Research, Pierre Fabre

Jerome Wojcik , CEO,Quartz Bio

Oleksandr Otava, Head Of Scientific IT, Affiris AG

Sowmyanarayan Srinivasan, Director R&D Practise,Global Delivery Leader Discovery

Pharma Supply Chain Europe 2016 , Return on Investment attained at the meeting and why they are coming back

Pharma Supply Chain Europe 2016 , Return on Investment attained at the meeting and why they are coming back

Pharma Supply Chain Europe 2016 , What they think of the roundtable discussion format

Pharma Supply Chain Europe 2016 , Level of delegation, attendee diversity and seniority

Pharma Supply Chain Europe 2016 , What they think of the 1-1 prequalified business meetings

Samuel T. Labrie, VP Corporate Development, Myriad RBM

Kam Dhaliwal, SVP Services & Alliances, Horizon Discovery

Matt Hersch, Clinical Operations Manager, GW Pharmaceuticals

Rainer Metzger, VP Global Business Development Pharma, Qiagen

Dilsaid Babayigit, Founder & CEO, Ageneo

John Apathy, Vice President, R&D informatics, Celgene

Lars Branden, Senor Director,Informatics R&D Division,Retro Screen Virology Ltd.

Dominic Clark , Industry Programme Manager,EMBL-EBI

Yike Guo, Director Data Science Institude, Imperial College London

John Wise, Executive Director, Pistoia Alliance

Abel Ureta-Vida, CEO, Eagle Genomics

Alexander Scheer, Deputy Head of Research, Pierre Fabre

Jerome Wojcik , CEO,Quartz Bio

Oleksandr Otava, Head Of Scientific IT, Affiris AG

Sowmyanarayan Srinivasan, Director R&D Practise,Global Delivery Leader Discovery

Location

Sofitel Munich Bayerstrasse 12 80335 Munich
Germany

Date: May 24, 2018 Time:7:30AM – 9:00PM

Book your seat for the Pharmacovigilance Europe 2018

DELEGATE REGISTRATION